Yamaguchi Hiroki, Sakaguchi Hirotoshi, Yoshida Kenichi, Yabe Miharu, Yabe Hiromasa, Okuno Yusuke, Muramatsu Hideki, Takahashi Yoshiyuki, Yui Shunsuke, Shiraishi Yuichi, Chiba Kenichi, Tanaka Hiroko, Miyano Satoru, Inokuchi Koiti, Ito Etsuro, Ogawa Seishi, Kojima Seiji
Department of Hematology, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-Ku, Tokyo, 113-8603, Japan.
Department of Pediatrics, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8560, Japan.
Int J Hematol. 2015 Nov;102(5):544-52. doi: 10.1007/s12185-015-1861-6. Epub 2015 Sep 2.
Dyskeratosis congenita (DKC) is an inherited bone marrow failure (BMF) syndrome typified by reticulated skin pigmentation, nail dystrophy, and mucosal leukoplakia. Hoyeraal-Hreidarsson syndrome (HHS) is considered to be a severe form of DKC. Unconventional forms of DKC, which develop slowly in adulthood but without the physical anomalies characteristic of DKC (cryptic DKC), have been reported. Clinical and genetic features of DKC have been investigated in Caucasian, Black, and Hispanic populations, but not in Asian populations. The present study aimed to determine the clinical and genetic features of DKC, HHS, and cryptic DKC among Japanese patients. We analyzed 16 patients diagnosed with DKC, three patients with HHS, and 15 patients with cryptic DKC. We found that platelet count was significantly more depressed than neutrophil count or hemoglobin value in DKC patients, and identified DKC patients with large deletions in the telomerase reverse transcriptase and cryptic DKC patients with RTEL1 mutations on both alleles. This led to some patients previously considered to have unclassifiable BMF being diagnosed with cDKC through identification of new gene mutations. It thus seems important from a clinical viewpoint to re-examine the clinical characteristics, frequency of genetic mutations, and treatment efficacy in DKC, HHS, and cDKC.
先天性角化不良(DKC)是一种遗传性骨髓衰竭(BMF)综合征,其典型特征为网状皮肤色素沉着、指甲营养不良和黏膜白斑。霍耶拉尔-赫雷达尔松综合征(HHS)被认为是DKC的一种严重形式。已经报道了非典型形式的DKC,其在成年期缓慢发展,但没有DKC的典型身体异常(隐匿性DKC)。在白种人、黑人和西班牙裔人群中对DKC的临床和遗传特征进行了研究,但在亚洲人群中尚未进行。本研究旨在确定日本患者中DKC、HHS和隐匿性DKC的临床和遗传特征。我们分析了16例诊断为DKC的患者、3例HHS患者和15例隐匿性DKC患者。我们发现,DKC患者的血小板计数比中性粒细胞计数或血红蛋白值明显更低,并鉴定出端粒酶逆转录酶存在大片段缺失的DKC患者以及两个等位基因均存在RTEL1突变的隐匿性DKC患者。这使得一些先前被认为患有无法分类的BMF的患者通过鉴定新的基因突变而被诊断为隐匿性DKC。因此,从临床角度重新审视DKC、HHS和隐匿性DKC的临床特征、基因突变频率和治疗效果似乎很重要。